[1]
“EVALUATING THE IMPACT OF MODERN ANTI-DIABETIC DRUGS ON SURVIVAL OUTCOMES IN LUNG CANCER PATIENTS WITH TYPE 2 DIABETES”, JMHSR, vol. 2, no. 3, Jul. 2025, doi: 10.62019/hmpfcj11.